Johns Hopkins Mar 8, 2021 Immunotherapy With Bispecific Antibodies Targets T Cells to Cancer Cells' Mutant Peptides Premium Mar 2, 2021 John Hopkins, Akoya Biosciences Ink Deal to Advance New Immunotherapy Biomarkers Nov 24, 2020 Clinicians Face New Intervention Questions as Clonal Hematopoiesis Mutation Data Evolves Premium Oct 27, 2020 Exact Sciences to Acquire Thrive Earlier Detection for up to $2.15B; Q3 Revenues Spike 87 Percent Apr 29, 2020 Pan-Cancer Screening Tests Report First Performance Numbers in Undiagnosed Cohorts Premium Jan 27, 2020 Johns Hopkins University Opens New Cancer Center With $5M in Mark Foundation Funding Jan 14, 2020 Immunotherapy Response Prediction Improves With TMB Correction, Other Markers Premium Oct 18, 2019 Colon Cancer Recurrence Clues Identified in Post-Treatment ctDNA Detection Sep 23, 2019 PGDx Shares New MSI Data, Provides Update on FDA Bid for Pan-Cancer IVDs Premium Aug 30, 2019 Hereditary Cancer Risk Variants Found in Significant Subset of Metastatic Breast Cancer Patients Jul 24, 2019 Gray Foundation Awards $25M in Cancer Research Grants Jun 2, 2019 Johns Hopkins Spinout to Bring CancerSEEK Test to Clinic Premium May 30, 2019 New Studies Examine Genetic, Environmental Risk Factors Linked to Lung Cancer Among Never Smokers Premium May 30, 2019 Liquid Biopsy Early Detection Firm Thrive Launches With $100M Series A Financing May 9, 2019 Circulating Tumor DNA Forecasts Recurrence in Non-Metastatic Colorectal Cancer Jun 14, 2018 Breast, Lung Cancer Genetics Highlight Mutations Linked to Drug Response, Prognosis Breaking News FDA Approves Taiho Oncology's Lytgobi for FGFR2-Rearranged Bile Duct Cancer Gladstone Institute Joins With Parker Institute on New Center to Study CRISPR-Based Cell Therapies Meliora Therapeutics Raises $11M in Seed Financing In Brief This Week:Â Verismo Therapeutics, Fore Biotherapeutics, Merck, Caris Life Sciences Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients Atara Biotherapeutics to Net $30M From Pierre Fabre for European Tab-Cel Approval
